These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 922113)

  • 1. Immunologic evaluation of rheumatoid arthritis and therapy with levamisole.
    Verhaegen H; de Cree J; de Cock W; Schuermans Y; Engels M; Sonck W
    Biomedicine; 1977 Jul; 26(4):283-91. PubMed ID: 922113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levamisole treatment of inflammatory acne. Restoration of impaired T-cell function accompanied by clearing of the lesions.
    De Cree J; De Cock W; Verhaegen H
    Biomedicine; 1979 Jul; 31(4):95-9. PubMed ID: 158397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurements of humoral immunity during treatment with levamisole in rheumatoid arthritis--a review.
    Vischer TL
    J Rheumatol Suppl; 1978; 4():49-53. PubMed ID: 282446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Controlled trial of levamisole in rheumatoid arthritis. Clinical and immunological study of 22 cases (author's transl)].
    Rondier J; Cayla J; Tron F; Roger M; Bach JF
    Nouv Presse Med; 1978 Oct; 7(34):3023-7, 3029-30. PubMed ID: 364409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum complement and immunoglobulin levels in sporadic and familial ankylosing spondylitis.
    Kinsella TD; Espinoza L; Vasey FB
    J Rheumatol; 1975 Sep; 2(3):308-13. PubMed ID: 1185743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular immune reactivity in patients with rheumatoid arthritis and effects of levamisole.
    Basch CM; Spitler LE; Engleman EG; Engleman EP
    J Rheumatol; 1977; 4(4):377-88. PubMed ID: 604477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restoration by levamisole of low E-rosette forming cells in patients suffering from various diseases.
    Verhaegen H; De Cree J; De Cock W; Verbruggen F
    Clin Exp Immunol; 1977 Feb; 27(2):313-8. PubMed ID: 321165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoglobulin and complement deposits in lupus glomerulonephritis.
    Méry JP; Morel-Maroger L; Boelaert J
    Proc Eur Dial Transplant Assoc; 1975; 11():506-11. PubMed ID: 1197274
    [No Abstract]   [Full Text] [Related]  

  • 9. Levamisole and cellular immunity in rheumatoid arthritis--clinical and laboratory correlates.
    Levy J
    J Rheumatol Suppl; 1978; 4():63-70. PubMed ID: 366145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Complement (C3)-activating material in synovial fluid from patients with rheumatoid arthritis].
    Stojan B
    Z Rheumatol; 1981; 40(5):208-12. PubMed ID: 6914866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of complement components in polyethylene glycol precipitated immune complexes from patients with ovarian cancer and patients with rheumatoid arthritis.
    Mooney NA; Hay FC; Poulton TA
    Clin Exp Immunol; 1983 Jun; 52(3):561-8. PubMed ID: 6603297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Serum complement levels in patients with rheumatoid arthritis and vasculitis].
    Tomooka K
    Fukuoka Igaku Zasshi; 1989 Oct; 80(10):456-66. PubMed ID: 2613159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Converse changes in serum levels of immunoglobulins (IgG, A and M) and complement components (C3, 4) during pregnancy].
    Yasuhara M; Tamaki H; Iyama S; Yamaguchi Y; Amino N; Miyai K
    Rinsho Byori; 1991 Nov; 39(11):1195-8. PubMed ID: 1762197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pleural fluid complement, complement conversion, and immune complexes in immunologic and nonimmunologic diseases.
    Hunder GG; McDuffie FC; Huston KA; Elveback LR; Hepper NG
    J Lab Clin Med; 1977 Dec; 90(6):971-80. PubMed ID: 597373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Elevated C3-proactivator serum levels in patients with chronic polyarthritis].
    Stojan B
    Z Rheumatol; 1976; 35(7-8):272-7. PubMed ID: 961078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of lymphocyte populations and their mitogenic activity in relation to serum copper and immunoglobulin levels in rheumatoid arthritis.
    Attia WM; Clark HW; Brown TM
    Ann Allergy; 1981 Aug; 47(2):99-103. PubMed ID: 7258747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of rheumatoid arthritis by levamisole. First results].
    Sany J; Morlock G; Clot J; Serre H
    Rev Rhum Mal Osteoartic; 1977 Mar; 44(3):143-53. PubMed ID: 322247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement activation in seropositive and seronegative rheumatoid arthritis. 125I-C1q binding capacity and complement breakdown products in serum and synovial fluid.
    Lambert PH; Nydegger UE; Perrin LH; McCormic J; Fehr K; Miescher PA
    Rheumatology; 1975; 6():52-9. PubMed ID: 1202608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Class specific rheumatoid factors in rheumatoid arthritis: response to chrysotherapy and relationship to disease activity.
    Rudge SR; Pound JD; Bossingham DH; Powell RJ
    J Rheumatol; 1985 Jun; 12(3):432-6. PubMed ID: 3930719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of classical complement pathway activation in rheumatoid arthritis: measurement of C1q-C4 complexes as novel activation products.
    Wouters D; Voskuyl AE; Molenaar ET; Dijkmans BA; Hack CE
    Arthritis Rheum; 2006 Apr; 54(4):1143-50. PubMed ID: 16572449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.